1. Home
  2. ATNM vs UONEK Comparison

ATNM vs UONEK Comparison

Compare ATNM & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.33

Market Cap

45.2M

Sector

Health Care

ML Signal

HOLD

Logo Urban One Inc. Class D

UONEK

Urban One Inc. Class D

HOLD

Current Price

$0.84

Market Cap

36.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
UONEK
Founded
2000
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
45.2M
36.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATNM
UONEK
Price
$1.33
$0.84
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
137.7K
29.3K
Earning Date
11-14-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$90,000.00
$393,670,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.11
N/A
52 Week Low
$1.03
$0.44
52 Week High
$2.41
$1.40

Technical Indicators

Market Signals
Indicator
ATNM
UONEK
Relative Strength Index (RSI) 42.97 47.40
Support Level $1.27 $0.80
Resistance Level $1.36 $0.94
Average True Range (ATR) 0.07 0.10
MACD -0.02 -0.01
Stochastic Oscillator 26.00 19.32

Price Performance

Historical Comparison
ATNM
UONEK

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: